• Our Partners
  • CarePolicy
  • HomeCareConsulting
  • Digit9X
  • Home
  • Assisted Living
  • Elderly
  • Home Care Agency
  • Home Care Worker
  • Home Nursing
Menu
  • Home
  • Assisted Living
  • Elderly
  • Home Care Agency
  • Home Care Worker
  • Home Nursing
Home » Healthcare stocks like Eli Lilly are set to soar in 2025: Citi
Elderly

Healthcare stocks like Eli Lilly are set to soar in 2025: Citi

adminBy adminDecember 27, 2024No Comments3 Mins Read
Facebook Twitter Pinterest Telegram LinkedIn Tumblr Email Reddit
Share
Facebook Twitter LinkedIn Pinterest Email Copy Link


Citi analysts expect healthcare segment earnings to grow 19% in 2025, up from 4% this year. Analysts point to the stock's fair-sized valuation and potential for improvement in fundamentals. The sector has lagged the S&P 500's gains this year. The index rose 26%, while the index rose just 1%.

After a tough year marked by policy uncertainty and lagging fundamentals, healthcare stocks will turn around in 2025, says Citi.

The company notes that after months of huge valuations, the sector's valuations have improved, offering an attractive entry point.

“One year makes a big difference. Relative underperformance and flat absolute returns over the past year have gradually eased valuation concerns,” analysts said in a note Monday.

The sector has lagged the broader market's gains this year, rising just 1.1%, while the S&P 500 index is up 26.2% so far.

Analysts also note that underlying fundamentals are below par and a bottom could be reached soon.

“This was the most persistent underweight throughout 2024, but valuations are appropriately sized and fundamentals appear to be nearing a tipping point,” the analysts said.

Overall, the healthcare sector is expected to deliver revenue growth of 19% in 2025, compared to the expected 4% this year.

Analysts' calls come after a difficult year for the industry amid great policy uncertainty, especially after President-elect Donald Trump nominated Robert F. Kennedy Jr. as Secretary of Health and Human Services. It was done.

President Kennedy was a vocal skeptic of vaccines. In the days after his appointment last month, vaccine makers including Moderna, Pfizer, Novavax and GSK plunged.

But some analysts have since said the reaction was overblown, especially for weight-loss drug makers like Wegoby, Ozempic maker Novo Nordisk and Zepbound maker Eli Lilly.

BMO analysts argued in a note last month that the decline “reflects fear rather than actual fundamental downside risks.”

They say there is little risk to the stock prices of companies like Eli Lilly and Novo Nordisk because Mr. Kennedy's role has limited authority to change policies that affect drug pricing and availability. He said that it is considered possible.

Citi analysts seem to agree, predicting a return of 64% for Eli Lilly, the sector's largest stock, at 12%.

“While policy debates remain, we believe this is largely priced in,” the analysts said, adding that pharma and biotech stocks could lead the sector's outperformance in 2025. He added that it is expensive.

The analysts' call comes as the company expands its shift to selective defensive stocks. Some cyclical stocks have rich valuations but little near-term earnings growth, he said.

“Some of the traditional defensive industry groups look interesting. Some cyclicals may need to buy time as they have rich valuations but haven't yet seen a turnaround in earnings growth.” analysts wrote.



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
admin
  • Website

Related Posts

PFE, NVS, and JNJ: The Shining Stars of the Slow Healthcare Sector

July 1, 2025

Just as healthcare leaders look at federal budgets, they look back on the incredibly helpful 2025 legislative session

June 30, 2025

Strong growth in the Healthcare Online Recruitment Market

June 30, 2025
Leave A Reply Cancel Reply

Top Posts

“The biggest cut ever”: CMS proposed home health payment rules shake up industry leaders

July 1, 2025

Understand Latin health at Adelantando Healthcare Conference

January 1, 1970

Seton Hall's new university university program explores women's healthcare for future health leaders

January 1, 1970

North Texas medical chain faces possible $300 million fine for 20,000 fake Medicare claims

January 28, 2003
Don't Miss

Call for nurses to take part in research on wellbeing and burnout

By adminJuly 1, 2025

Researchers from Yorkshire is asking for UK nursing staff to help with her study into…

Former senior leaders at Lucy Letby’s hospital trust arrested

July 1, 2025

UK Covid-19 Inquiry begins evidence sessions on adult social care| Nursing Times

July 1, 2025

Tributes paid to specialist trust chief nurse who ‘led with love’

June 30, 2025

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

About Us
About Us

Welcome to HomeCareNews.us, your trusted source for comprehensive information on home healthcare services. Our mission is to empower individuals and families by providing accurate, up-to-date, and insightful information about essential home care services in USA.

Facebook X (Twitter) Pinterest YouTube WhatsApp
Our Picks

“The biggest cut ever”: CMS proposed home health payment rules shake up industry leaders

July 1, 2025

PFE, NVS, and JNJ: The Shining Stars of the Slow Healthcare Sector

July 1, 2025

Call for nurses to take part in research on wellbeing and burnout

July 1, 2025
Most Popular

“The biggest cut ever”: CMS proposed home health payment rules shake up industry leaders

July 1, 2025

Understand Latin health at Adelantando Healthcare Conference

January 1, 1970

Seton Hall's new university university program explores women's healthcare for future health leaders

January 1, 1970
  • Home
  • About Us
  • Advertise with Us
  • Contact us
  • DMCA Policy
  • Privacy Policy
  • Terms & Conditions
© 2025 HomecareNews.US

Type above and press Enter to search. Press Esc to cancel.